aap 2007: Strong sales growth to EUR 28.1 million (+52%) due to fourth quarter’s sales record

aap Implantate AG, a medical technology company listed on the Frankfurt Stock Exchange in the Prime Standard segment, achieved in the fourth quarter of the financial year 2007 - according to preliminary figures - a quarterly sales record of EUR 9.5 million (+121% to fourth quarter 2006). Sales of total financial year 2007 were up to a new level of EUR 28.1 million, a year-to-year increase of 52%.

In 2007, the group companies active in the field of medical biomaterials („aap bio implants group“), achieved sales of EUR 20.1 million (previous year: EUR 12.2 million, + 65%). This significant increase results to a large extent from the acquisition and initial consolidation of the Dutch Fame Medical Group.

The Berlin based trauma & orthopaedics division of the company reached for the full financial year 2007 a strong organic sales increase of 29% to EUR 8.0 million (previous year: EUR 6.2 million).

For 2008 aap anticipates an organic sales growth of more than 20%, with above-average impact of the company´s operating result and net income. The publication of the full annual financial statements 2007 is planned for March 28, 2008.